Latest article
Novo Nordisk, following in Lilly’s Trulicity footsteps, recordsdata increased Ozempic dose for diabetes
Novo Nordisk and Eli Lilly are embroiled in an uphill battle, both fighting for the top spot in the GLP-1 diabetes treatment class. ...
Zinc may very well be key to new diabetes therapies
Researchers at the University of St. Andrews say a better understanding of how our bodies handle zinc could lead to improved treatment for people...
